Search results

Interesting you're part of a low-risk study! Just shows where valve-replacement is going. I'm sure you will be happy whatever way you go... It will certainly make you feel better than you do now! Good luck

Thanks Pellicle... Looks like CoryP had a great experience. His thoughts about valve-in-valve appear to be just questions and speculation. We have no idea how many valve-in-valves will be able to be done, or how it will affect flow, until those studies and first eligible patients have gone...

I would ask the Cardiologist if calcium is of concern before making a decision to go through this. This was FDA approved for those with severe aortic stenosis of intermediate to high risk, and proved to be safer than surgery. Many people with AS have calcification, so the stent must mitigate...

Select groups being intermediate to high risk. If someone was low risk, perhaps it would be better to get the latest biologic valve, such as the St Jude Trifecta GT or Edwards Magna Ease. Open Heart isn't so bad the first time around. Low-risk person could then wait till the TAVR tissue got...

Pellicle, I think your quote from the New England Journal of Medicine answered why TAVR was safer for intermediate risk patients than surgery: "At 2 years, the Kaplan–Meier event rates were 19.3% in the TAVR group and 21.1% in the surgery group" "In the transfemoral-access cohort, TAVR...

Never thought we'd see the day, but TAVR has been proven safer than surgical VR and was FDA approved today for intermediate risk! This is great news for all of us, and is truly a game changer. Many exciting things going on in the world of valve replacement right now...

SJM makes many of our valves. Thought you should know they will become Abbott... http://www.usatoday.com/story/money/2016/04/28/abbott-laboratories-st-jude-medical-acquisition/83638548/

.............

Interesting about the Edwards valve, so maybe this GT version is just easier to install

A new version of the St. Jude Trifecta was approved today in Europe. It appears to be the same valve, but with "Glide Technology". Appears to be easier to implant, and I understand what improved seating is, but can anyone explain what improved "parachuting" is??? Thanks...

Big news out of Edwards today. Their stock went through the roof. New study results confirm: "Results revealed at the American College of Cardiology conference on Sunday are certain to bolster the firm’s case for a broader indication. So-called TAVR procedures performed with Sapien 3 led to...

Here is another source of life expectancy info. See the quote below and the original article link: "Long-term survival following aortic valve replacement is close to that observed in a control population of similar age. Numerous observational studies have consistently demonstrated that...

The author doesn't site any examples or studies, kind of odd. Also doesn't say exactly "why" people got valve disease to begin with. The "why" could lead others to lower life expectancies and have nothing to do with the valve itself.

Of course, the terminator is indestructible... Can't beat that!

Not likely, haha.... Another thing to consider is that TAVR technology would be most likely to first use tissue derived from stem cells in the future. Imagine have a TAVR procedure, or VIV, using tissue that doesn't degrade? Study below: http://www.ncbi.nlm.nih.gov/m/pubmed/22917460/

New TAVR indications and trial for low-risk! Check out... http://www.valvereplacement.org/forums/forum/heart-talk/863223-tavr-trial-for-low-risk-bright-future-ahead?_=1456936316661

I just posted an update on TAVR and Valve-in-valve that you guys should really check out. Too bad I can't link it to this forum as well... http://www.valvereplacement.org/forums/forum/heart-talk/863223-tavr-trial-for-low-risk-bright-future-ahead?_=1456936316661

VIV already approved even for smaller sizes... "During the VIV procedure, the CoreValve System is placed inside a failing surgical heart valve with an inner diameter from 17-29 mm through a low-profile, 18Fr delivery catheter, which is approved for use with all four CoreValve sizes (23mm, 26mm...

That being said, right now I would probably prefer an open heart biologic that is expertly fitted and sewn in by a surgeon. But it does look like, someday after this trial concludes and has results, that TAVR may be preferred in low risk.

That is a great way to look at it. I am also similarly cautiously optimistic. However, the speed of these product approvals is amazing. Just this morning, Edwards got approval for TAVR in pulmonic procedures...